San Diego, August 1, 2017 — ViaCyte, Inc., a privately - held, leading regenerative medicine company, announced today that the first patients have been implanted with the PEC - Direct ™ product candidate,
a novel islet cell replacement therapy in development as a functional cure for patients with type 1 diabetes who are at high risk for acute life - threatening complications.
Not exact matches
Islet cell transplantation research in the UK The success of a novel islet transplantation procedure, called the «Edmonton protocol» was reported in an article in the New England Journal of Medicine, 27 July
Islet cell transplantation research in the UK The success of a
novel islet transplantation procedure, called the «Edmonton protocol» was reported in an article in the New England Journal of Medicine, 27 July
islet transplantation procedure, called the «Edmonton protocol» was reported in an article in the New England Journal of Medicine, 27 July 2000.
To corroborate the findings, the researchers also developed a
novel mouse model that was deficient for autophagy specifically in beta
cells with expression of the human form of
islet amyloid polypeptide.
The encapsulation of pancreatic
islets within mainly alginate - based macro - or microcapsules with various physical configurations may allow protecting the
islet graft without the need for immunosuppressive agents and moreover expanding the donor pool to animal tissue and
novel insulin - producing
cells.
Coating Human Pancreatic
Islets With CD4 + CD25highCD127 - Regulatory T
Cells as a
Novel Approach for the Local Immunoprotection.
Our group is specifically working on improvement of
islet isolation and transplantation protocols in clinical practice and the development of
novel therapeutic options in the field of beta
cell replacement with a clear translational «bench to bedside» approach by linking experimental research with preclinical and clinical work:
A
novel investigative study published in the Nov 2014 issue of the Journal of Endocrinology looked at the effects of curcumin on insulin - producing
cells within the pancreas called Beta
cells (or B -
cells) and
Islet cells, in relation to imbalanced blood sugar.